Ataxia in a chronic kidney disease patient on anti-tubercular therapy

Isoniazid is the mainstay of anti-tubercular therapy. Used in isolation or in combination with other anti-tubercular drugs, it is generally well-tolerated. While hepatotoxicity and neurotoxicity are reported, significant neurotoxicity remains uncommon. In this report, we present a case of rare neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathania, D., Phanish, M. K., Vishal, J., Kher, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753744/
https://www.ncbi.nlm.nih.gov/pubmed/26937081
http://dx.doi.org/10.4103/0971-4065.157803
_version_ 1782415911133642752
author Pathania, D.
Phanish, M. K.
Vishal, J.
Kher, V.
author_facet Pathania, D.
Phanish, M. K.
Vishal, J.
Kher, V.
author_sort Pathania, D.
collection PubMed
description Isoniazid is the mainstay of anti-tubercular therapy. Used in isolation or in combination with other anti-tubercular drugs, it is generally well-tolerated. While hepatotoxicity and neurotoxicity are reported, significant neurotoxicity remains uncommon. In this report, we present a case of rare neurological complication secondary to anti-tubercular therapy in a patient with stage 5 chronic kidney disease.
format Online
Article
Text
id pubmed-4753744
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-47537442016-03-02 Ataxia in a chronic kidney disease patient on anti-tubercular therapy Pathania, D. Phanish, M. K. Vishal, J. Kher, V. Indian J Nephrol Case Report Isoniazid is the mainstay of anti-tubercular therapy. Used in isolation or in combination with other anti-tubercular drugs, it is generally well-tolerated. While hepatotoxicity and neurotoxicity are reported, significant neurotoxicity remains uncommon. In this report, we present a case of rare neurological complication secondary to anti-tubercular therapy in a patient with stage 5 chronic kidney disease. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4753744/ /pubmed/26937081 http://dx.doi.org/10.4103/0971-4065.157803 Text en Copyright: © 2016 Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Pathania, D.
Phanish, M. K.
Vishal, J.
Kher, V.
Ataxia in a chronic kidney disease patient on anti-tubercular therapy
title Ataxia in a chronic kidney disease patient on anti-tubercular therapy
title_full Ataxia in a chronic kidney disease patient on anti-tubercular therapy
title_fullStr Ataxia in a chronic kidney disease patient on anti-tubercular therapy
title_full_unstemmed Ataxia in a chronic kidney disease patient on anti-tubercular therapy
title_short Ataxia in a chronic kidney disease patient on anti-tubercular therapy
title_sort ataxia in a chronic kidney disease patient on anti-tubercular therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753744/
https://www.ncbi.nlm.nih.gov/pubmed/26937081
http://dx.doi.org/10.4103/0971-4065.157803
work_keys_str_mv AT pathaniad ataxiainachronickidneydiseasepatientonantituberculartherapy
AT phanishmk ataxiainachronickidneydiseasepatientonantituberculartherapy
AT vishalj ataxiainachronickidneydiseasepatientonantituberculartherapy
AT kherv ataxiainachronickidneydiseasepatientonantituberculartherapy

Ejemplares similares